Neogen (NEOG) Stock: Buy, Sell, or Hold?
NEOG - Neogen Corp
$12.24
-0.56 (-4.38%)
▼
5d:
-10.4%
30d:
+5.15%
90d:
+31.05%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 06, 2026
4d
Get Alerted When NEOG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NEOG is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NEOG is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.26
Based on 4.3% avg growth
INTRINSIC VALUE TODAY
$5.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEOG is currently trading at $12.24, which is considered fair relative to its 30-day fair value range of $11.59 to $13.20. From a valuation perspective, the stock is trading at a premium (Forward PE: 42.7) compared to its historical average (31.2). At these levels, the market is pricing in 11.0% annual earnings growth.
Technical Outlook: Technically, NEOG is in a strong uptrend. The price is currently testing key support at $12.33. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NEOG scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NEOG is in a strong uptrend. The price is currently testing key support at $12.33. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NEOG scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$11.59 -
$13.20
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
43.8%
Protect Your Profits
Holding NEOG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (37/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- NEUTRAL: Near Wall St target ($13.33)
- BULLISH: Expecting earnings turnaround to 11.0% growth with -0.1% revenue growth
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$11.59 -
$13.20
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$12.33
Resistance Level
$14.26
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
42.67
Wall Street Target
$13.33
(+4.2%)
Revenue Growth (YoY)
-0.1%
Earnings Growth (YoY)
-85.6%
Profit Margin
-0.9%
Valuation Premium vs History
+11.0% premium
PE vs Historical
42.7 vs 31.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.0%
(market-implied from PE analysis)
1-Year Target
$14.21
(+11%)
2-Year Target
$15.77
(+23%)
3-Year Target
$17.51
(+37%)
3-Yr Target (if PE normalizes)
(PE: 43→31)
PE COMPRESSION
$12.80
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 42.7, Growth: 4.6%)
$14.67
(+15%)
Base:
(SPY PE: 20.4, Growth: 4.6%)
$7.01
(-45%)
Bear:
(PE: 17.3, Growth: 4.6%)
$5.96
(-53%)
Share & Embed Analysis
Last updated: October 01, 2026 4:09 PM ET
Data refreshes hourly during market hours. Next update: 5:09 PM
Data refreshes hourly during market hours. Next update: 5:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEOG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 48 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 57 HOLD |
Advanced NEOG Option Strategies
Professional options setups generated by AI based on today's NEOG price and gamma walls.
